Hepatitis B Virus Variants with Multiple Insertions and/or Deletions in the X Open Reading Frame 3' End: Common Members of Viral Quasispecies in Chronic Hepatitis B Patients.
Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
5 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors at 4 institutions in 2 countries.
Selene García-GarcíaLiver Pathology Unit, Departments of Biochemistry and Microbiology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.ORCID 0000-0001-7697-2058
Andrea Caballero-GarraldaLiver Pathology Unit, Departments of Biochemistry and Microbiology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
David TaberneroLiver Pathology Unit, Departments of Biochemistry and Microbiology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.ORCID 0000-0002-1146-4084
Maria Francesca CorteseLiver Pathology Unit, Departments of Biochemistry and Microbiology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.ORCID 0000-0002-4318-532X
Josep GregoriCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-4253-8015
Francisco Rodriguez-AlgarraBlizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.ORCID 0000-0002-4134-2141
Josep QuerCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0003-0014-084X
Mar Riveiro-BarcielaCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Maria HomsAnoia Primary Care Service, Territorial Management of Central Catalonia, Catalan Institute of Health, 08700 Igualada, Spain.ORCID 0000-0002-8370-8375
Ariadna Rando-SeguraLiver Pathology Unit, Departments of Biochemistry and Microbiology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.ORCID 0000-0003-4555-7286
Beatriz Pacin-RuizLiver Pathology Unit, Departments of Biochemistry and Microbiology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Marta VilaLiver Pathology Unit, Departments of Biochemistry and Microbiology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Roser Ferrer-CostaLiver Pathology Unit, Departments of Biochemistry and Microbiology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.ORCID 0000-0002-8925-3172
Tomas PumarolaDepartment of Microbiology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Maria ButiCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Francisco Rodriguez-FriasLiver Pathology Unit, Departments of Biochemistry and Microbiology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.ORCID 0000-0002-9128-7013
Instituto de Salud Carlos III · ESVall d'Hebron Hospital Universitari · ESUniversitat Autònoma de Barcelona · ESQueen Mary University of London · GB
Funding
Centre for Industrial Technological Development IDI-20200297Instituto de Salud Carlos III PI18/01436Instituto de Salud Carlos III PI19/00301
6 · The paper itself
Abstract
Deletions in the 3' end region of the hepatitis B virus (HBV) X open reading frame (
Indexed as
deletionsHBX 3′ end regionhepatitis B virushepatitis B X open reading frameinsertionsnext-generation sequencingquasispecies
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Hepatitis B Virus Variants with Multiple Insertions and/or Deletions in the X Open Reading Frame 3' End: Common Members of Viral Quasispecies in Chronic Hepatitis B Patients. · full record | OpenQuestion